Organon (OGN) Consolidated Net Income (2020 - 2026)

Organon's Consolidated Net Income history runs 6 years deep, the most recent figure standing at $146.0 million for Q1 2026.

• In Q1 2026, Consolidated Net Income rose 67.82% year-over-year to $146.0 million; the TTM figure through Mar 2026 stood at $246.0 million (down 67.2% YoY), while the FY2025 annual figure was $187.0 million, down 78.36% from the prior year.
• Consolidated Net Income was $146.0 million for Q1 2026 at Organon, up from -$205.0 million in the prior quarter.
• In the past five years, Consolidated Net Income ranged from a high of $546.0 million in Q4 2023 to a low of -$205.0 million in Q4 2025.
• Historically, Consolidated Net Income has averaged $170.8 million across 4 years, with a median of $160.0 million in 2025.
• The sharpest annual moves came in 2024 and 2025: Consolidated Net Income jumped 518.97% in 2024, then sank 288.07% in 2025.
• A 4-year view of Consolidated Net Income shows it stood at $546.0 million in 2023, then plunged by 80.04% to $109.0 million in 2024, then tumbled by 288.07% to -$205.0 million in 2025, then jumped by 171.22% to $146.0 million in 2026.
• The last three Consolidated Net Income figures came in at $146.0 million (Q1 2026), -$205.0 million (Q4 2025), and $160.0 million (Q3 2025), per Business Quant data.